Study on B7-H3 Targeted Affibody Radioligand Probes for PET Imaging of Solid Tumors
Clinical trial NCT06454955 · RECRUITING
Trial details
- NCT number
- NCT06454955
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-01
- Primary completion
- 2024-11-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.